Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
16.82
-0.36 (-2.10%)
At close: Jun 17, 2025, 10:28 AM
Spyre Therapeutics Revenue
Spyre Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Spyre Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
73
Market Cap
1.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|